Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2019

Mar 5, 2019

30339_dirs_2019-03-05_2cec5751-ee96-4887-af6e-e3710fc56355.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2019-03-01

Reporting Person: Favorite Annette F (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-03-01 Common Stock A 1332.00 $106.14 Acquired 4802.8147 Indirect

Footnotes

F1: Bonus & Incentive share grant